Related Articles
Calreticulin is an effective immunologic adjuvant to tumor‑associated antigens
SOCS1 silencing can break high-dose dendritic cell immunotherapy-induced immune tolerance
Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin
Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus
Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma